AG
EPIX

Advisor Group’s ESSA Pharma EPIX Stock Holding History

Advisor Group’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$47K Buy
+8,500
New +$39.5K ﹤0.01% 3458

Other funds holding EPIX

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Advisor Group's EPIX Position: Q4 2019 in Review

Advisor Group opened a new position in ESSA Pharma (EPIX) in Q4 2019: 8,500 shares worth $47K. The stake represents ﹤0.01% of the portfolio and ranks #3458 among its holdings.

21 funds tracked by Wall St. Rank hold EPIX as of Q4 2019.

  • Advisor Group held 8,500 shares of ESSA Pharma worth $47K as of Q4 2019.
  • ESSA Pharma was a new Advisor Group position in Q4 2019.
  • ESSA Pharma made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3458 holding.
  • 21 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.